119 related articles for article (PubMed ID: 12883362)
1. Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin.
Debniak T; Górski B; Cybulski C; Jakubowska A; Kurzawski G; Lener M; Mierzejewski M; Masojć B; Medrek K; Kładny J; Załuga E; Maleszka R; Chosia M; Lubiński J
Melanoma Res; 2003 Aug; 13(4):365-70. PubMed ID: 12883362
[TBL] [Abstract][Full Text] [Related]
2. Germline 657del5 mutation in the NBS1 gene in breast cancer patients.
Górski B; Debniak T; Masojć B; Mierzejewski M; Medrek K; Cybulski C; Jakubowska A; Kurzawski G; Chosia M; Scott R; Lubiński J
Int J Cancer; 2003 Sep; 106(3):379-81. PubMed ID: 12845677
[TBL] [Abstract][Full Text] [Related]
3. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland.
Steffen J; Varon R; Mosor M; Maneva G; Maurer M; Stumm M; Nowakowska D; Rubach M; Kosakowska E; Ruka W; Nowecki Z; Rutkowski P; Demkow T; Sadowska M; Bidziński M; Gawrychowski K; Sperling K
Int J Cancer; 2004 Aug; 111(1):67-71. PubMed ID: 15185344
[TBL] [Abstract][Full Text] [Related]
4. Rarity of germline 1100delC mutation in CHK2 in patients with malignant melanoma of the skin.
Debniak T; Górski B; Cybulski C; Kurzawski G; Złowocka E; Kładny J; Chosia M; Lubiński J
Melanoma Res; 2004 Apr; 14(2):121-4. PubMed ID: 15057041
[TBL] [Abstract][Full Text] [Related]
5. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
Buslov KG; Iyevleva AG; Chekmariova EV; Suspitsin EN; Togo AV; Kuligina ESh; Sokolenko AP; Matsko DE; Turkevich EA; Lazareva YR; Chagunava OL; Bit-Sava EM; Semiglazov VF; Devilee P; Cornelisse C; Hanson KP; Imyanitov EN
Int J Cancer; 2005 Apr; 114(4):585-9. PubMed ID: 15578693
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland.
Steffen J; Nowakowska D; Niwińska A; Czapczak D; Kluska A; Piatkowska M; Wiśniewska A; Paszko Z
Int J Cancer; 2006 Jul; 119(2):472-5. PubMed ID: 16770759
[TBL] [Abstract][Full Text] [Related]
7. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic analysis of NBS1 in German melanoma patients.
Meyer P; Stapelmann H; Frank B; Varon R; Burwinkel B; Schmitt C; Boettger MB; Klaes R; Sperling K; Hemminki K; Kammerer S
Melanoma Res; 2007 Apr; 17(2):109-16. PubMed ID: 17496786
[TBL] [Abstract][Full Text] [Related]
9. NBS1 is a prostate cancer susceptibility gene.
Cybulski C; Górski B; Debniak T; Gliniewicz B; Mierzejewski M; Masojć B; Jakubowska A; Matyjasik J; Złowocka E; Sikorski A; Narod SA; Lubiński J
Cancer Res; 2004 Feb; 64(4):1215-9. PubMed ID: 14973119
[TBL] [Abstract][Full Text] [Related]
10. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation.
Steffen J; Maneva G; Popławska L; Varon R; Mioduszewska O; Sperling K
Int J Cancer; 2006 Dec; 119(12):2970-3. PubMed ID: 16998789
[TBL] [Abstract][Full Text] [Related]
12. RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.
Heikkinen K; Rapakko K; Karppinen SM; Erkko H; Knuutila S; Lundán T; Mannermaa A; Børresen-Dale AL; Borg A; Barkardottir RB; Petrini J; Winqvist R
Carcinogenesis; 2006 Aug; 27(8):1593-9. PubMed ID: 16474176
[TBL] [Abstract][Full Text] [Related]
13. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies.
Chrzanowska KH; Piekutowska-Abramczuk D; Popowska E; Gładkowska-Dura M; Małdyk J; Syczewska M; Krajewska-Walasek M; Goryluk-Kozakiewicz B; Bubała H; Gadomski A; Gaworczyk A; Kazanowska B; Kołtan A; Kuźmicz M; Luszawska-Kutrzeba T; Maciejka-Kapuścińska L; Stolarska M; Stefańska K; Sznurkowska K; Wakulińska A; Wieczorek M; Szczepański T; Kowalczyk J
Int J Cancer; 2006 Mar; 118(5):1269-74. PubMed ID: 16152606
[TBL] [Abstract][Full Text] [Related]
14. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
Sokolenko AP; Bogdanova N; Kluzniak W; Preobrazhenskaya EV; Kuligina ES; Iyevleva AG; Aleksakhina SN; Mitiushkina NV; Gorodnova TV; Bessonov AA; Togo AV; Lubiński J; Cybulski C; Jakubowska A; Dörk T; Imyanitov EN
Breast Cancer Res Treat; 2014 Jun; 145(2):553-62. PubMed ID: 24800916
[TBL] [Abstract][Full Text] [Related]
15. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
17. Allelic modification of breast cancer risk in women with an NBN mutation.
Rusak B; Kluźniak W; Wokołorczyk D; Stempa K; Kashyap A; Rudnicka H; Gronwald J; Huzarski T; Dębniak T; Jakubowska A; Szwiec M; Akbari MR; Narod SA; Lubiński J; Cybulski C;
Breast Cancer Res Treat; 2019 Nov; 178(2):427-431. PubMed ID: 31410679
[TBL] [Abstract][Full Text] [Related]
18. Regional distribution of heterozygous 657del5 mutation carriers of the NBS1 gene in Wielkopolska province (Poland).
Ziółkowska I; Mosor M; Nowak J
J Appl Genet; 2006; 47(3):269-72. PubMed ID: 16877808
[TBL] [Abstract][Full Text] [Related]
19. Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.
Auroy S; Avril MF; Chompret A; Pham D; Goldstein AM; Bianchi-Scarrà G; Frebourg T; Joly P; Spatz A; Rubino C; Demenais F; Bressac-de Paillerets B;
Genes Chromosomes Cancer; 2001 Nov; 32(3):195-202. PubMed ID: 11579459
[TBL] [Abstract][Full Text] [Related]
20. 657del5 mutation of the Nijmegen breakage syndrome gene (NBS1) in the Turkish population.
Tekin M; Akcayoz D; Ucar C; Gulen H; Akar N
Hum Biol; 2005 Jun; 77(3):393-7. PubMed ID: 16392640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
